rhenium has been researched along with Acute Lymphoid Leukemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchmann, I; Bunjes, D; Mutschler, J; Reske, SN; Steinbach, G | 1 |
| Döbert, N; Grünwald, F; Klein, SA; Kranert, WT; Martin, H; Menzel, C; Mose, S | 1 |
| Bartkowiak, D; Bunjes, D; Dohr, D; Röttinger, EM; Wennauer, R | 1 |
| Buchmann, I; Buck, A; Bunjes, D; Döhner, H; Glatting, G; Kotzerke, J; Martin, H; Rattat, D; Reske, SN; Seitz, U | 1 |
4 other study(ies) available for rhenium and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
[Myeloablative radioimmunotherapy with 188Re-CD66mAb before stem cell transplantation. No increase of proinflammatory cytokine levels of TNF-alpha].
Topics: Adult; Antibodies, Monoclonal; Antigens, CD; Cell Adhesion Molecules; Child; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radioimmunotherapy; Radioisotopes; Rhenium; Stem Cell Transplantation; Tumor Necrosis Factor-alpha; Young Adult | 2009 |
Re-186 HEDP conditioning therapy in patients with advanced acute lymphoblastic leukemia before allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Etidronic Acid; Humans; Kidney; Male; Organometallic Compounds; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rhenium; Transplantation Conditioning | 2003 |
Enhanced renal toxicity of total body irradiation combined with radioimmunotherapy.
Topics: Adolescent; Adult; Animals; Creatinine; Dose Fractionation, Radiation; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Kidney; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Dosage; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Rats; Rhenium; Stem Cell Transplantation; Time Factors; Whole-Body Irradiation | 2003 |
Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicities.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Bone Marrow; Cell Adhesion Molecules; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Liver; Lung; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Dosage; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Rhenium; Survival Rate; Tissue Distribution; Transplantation Conditioning | 2002 |